{"id":33887,"date":"2014-10-14T08:57:53","date_gmt":"2014-10-14T12:57:53","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=33887"},"modified":"2014-10-14T08:57:53","modified_gmt":"2014-10-14T12:57:53","slug":"trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887","title":{"rendered":"Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV)"},"content":{"rendered":"

Boston, MA 10\/14\/2014 (wallstreetpr) \u2013 <\/strong>Dynavax Technologies Corporation (NASDAQ:DVAX) announced<\/a> on 13th October that it had initiated phase 1\/2 clinical trials of its drug candidate SD-101. The target drug is expected to treat \u201clymphoma.\u201d The drug would be tested across multiple study centres and will be introduced into the patient intratumorally. The treatment would be running co-terminus with low dose radiation therapy. Company CEO Eddie Gray has indicated that the starting of the clinical trial is a important milestone since it demonstrates the maturity of its past few years drug development efforts. During the current testing cycle, nearly 25 patients who are suffering from B cell Lymphomas will be administered the test drug.<\/p>\n

Drug maker Cesca Therapeutics Inc. (NASDAQ:KOOL) announced<\/a> on 13th October that the firm had successfully bid for and has been awarded a new contract by Upstate Medical University. The contract involves providing a \u201ccell storage, processing and consumables platform\u201d to the Upstate Cord Blood Bank operated by the Upstate Medical University. Upstate Cord Blood Bank facility was recently set up at a cost of $15 million. It is located in New York. It will be collecting the \u201cumbilical cord blood\u201d which would be donated by concerned families. The cord blood would be used to further the development of \u201clife-saving medical treatments and for medical research\u201d. Cesca Therapeutics Inc. (NASDAQ:KOOL) Chief Executive Officer Matthew Plavan has described the deal as a key win for his company\u2019s nascent cord blood business.<\/p>\n

F5 Networks (NASDAQ:FFIV) announced on 13th October that it has secured an award which differentiates it as the \u201cthe industry’s top Web Application Firewall (WAF) vendor.\u201d The recognition came its way after NSS Labs benchmarked all vendors in this space few months back. The firm\u2019s \u201cApplication Security Manager\u2122\u201d has won the \u201crecommended\u201d status when compared against similar solutions from completion. The NSS report findings allows prospective buyers to compare technology before making their buying decision.<\/p>\n","protected":false},"excerpt":{"rendered":"

Boston, MA 10\/14\/2014 (wallstreetpr) \u2013 Dynavax Technologies Corporation (NASDAQ:DVAX) announced on 13th October that it had initiated phase 1\/2 clinical trials of its drug candidate […]<\/p>\n","protected":false},"author":2,"featured_media":33888,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[2236],"tags":[10855,10854,10853,1988,743,10857,991,744,10856],"stock_ticker":[],"class_list":["post-33887","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-cesca-therapeutics-inc","tag-cesca-therapeutics-inc-nasdaqkool","tag-dynavax-technologies-corporation","tag-dynavax-technologies-corporation-nasdaqdvax","tag-f5-networks","tag-f5-networks-nasdaqffiv","tag-nasdaqdvax","tag-nasdaqffiv","tag-nasdaqkool","entry"],"acf":[],"yoast_head":"\nTrending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV) - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV) - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/14\/2014 (wallstreetpr) \u2013 Dynavax Technologies Corporation (NASDAQ:DVAX) announced on 13th October that it had initiated phase 1\/2 clinical trials of its drug candidate […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2014-10-14T12:57:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/pg-28-delhi-afp-getty.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV)\",\"datePublished\":\"2014-10-14T12:57:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887\"},\"wordCount\":334,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/pg-28-delhi-afp-getty.jpg\",\"keywords\":[\"Cesca Therapeutics Inc.\",\"Cesca Therapeutics Inc. (NASDAQ:KOOL)\",\"Dynavax Technologies Corporation\",\"Dynavax Technologies Corporation (NASDAQ:DVAX)\",\"F5 Networks\",\"F5 Networks (NASDAQ:FFIV)\",\"NASDAQ:DVAX\",\"NASDAQ:FFIV\",\"NASDAQ:KOOL\"],\"articleSection\":[\"Business\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887\",\"name\":\"Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV) - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/pg-28-delhi-afp-getty.jpg\",\"datePublished\":\"2014-10-14T12:57:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/pg-28-delhi-afp-getty.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/pg-28-delhi-afp-getty.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV) - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887","og_locale":"en_US","og_type":"article","og_title":"Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV) - Wall Street PR","og_description":"Boston, MA 10\/14\/2014 (wallstreetpr) \u2013 Dynavax Technologies Corporation (NASDAQ:DVAX) announced on 13th October that it had initiated phase 1\/2 clinical trials of its drug candidate […]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2014-10-14T12:57:53+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/pg-28-delhi-afp-getty.jpg","type":"image\/jpeg"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV)","datePublished":"2014-10-14T12:57:53+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887"},"wordCount":334,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/pg-28-delhi-afp-getty.jpg","keywords":["Cesca Therapeutics Inc.","Cesca Therapeutics Inc. (NASDAQ:KOOL)","Dynavax Technologies Corporation","Dynavax Technologies Corporation (NASDAQ:DVAX)","F5 Networks","F5 Networks (NASDAQ:FFIV)","NASDAQ:DVAX","NASDAQ:FFIV","NASDAQ:KOOL"],"articleSection":["Business"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887","url":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887","name":"Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV) - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/pg-28-delhi-afp-getty.jpg","datePublished":"2014-10-14T12:57:53+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/pg-28-delhi-afp-getty.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2014\/10\/pg-28-delhi-afp-getty.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/trending-stocks-dynavax-technologies-corporation-nasdaqdvax-cesca-therapeutics-inc-nasdaqkool-f5-networks-nasdaqffiv-33887#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Trending Stocks: Dynavax Technologies Corporation (NASDAQ:DVAX), Cesca Therapeutics Inc. (NASDAQ:KOOL), F5 Networks (NASDAQ:FFIV)"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/33887","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=33887"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/33887\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/33888"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=33887"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=33887"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=33887"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=33887"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}